Suma Pharmaceuticals Private Limited

Suma Pharmaceuticals Private Limited - pharma in Ambernath, Maharashtra, India. FY 2026 financials & compliance.
CIN U27100MH1991PTC062830 Incorporated 06 August 1991 ROC Mumbai HQ Ambernath, Maharashtra, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹15.75 Cr
▲ 9% YoY
Net loss · FY 2024
₹46.31 Lakh
Net margin -2.9%
EBITDA · FY 2024
₹2.66 Cr
EBITDA margin 16.9%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.45 Cr
Issued & subscribed
Open charges
₹58.58 Cr
Satisfied ₹26.16 Cr
Company age
35 yrs
Est. 1991
Employees · EPFO
15
Provident fund records

About Suma Pharmaceuticals Private Limited

Data last updated:

Suma Pharmaceuticals Private Limited is a private limited company based in Ambernath, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 August 1991 and has been in existence for over 35 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U27100MH1991PTC062830. Its GSTIN is 27AAGCS1935H1ZA (Maharashtra).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.45 Cr. It was formerly known as Fast Real Honest Fabricators Private Limited. It is led by directors Sumati Ganpat Patil and Ganpat Mahadev Patil.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.126 Chikhloli MIDC New Bhendipada, Ambernath, Maharashtra, India – 421501.

As per the financials filed for FY 2024, the company reported a revenue of ₹15.75 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹46.31 Lakh (net margin -2.9%) and EBITDA of ₹2.66 Cr (EBITDA margin 16.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 37% over five years.

The company has about 15 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹58.58 Cr and satisfied charges of ₹26.16 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

Suma Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0035354). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sumapharma.in.

Company details

CIN U27100MH1991PTC062830
Registration Number 062830
Incorporation Date 06 August 1991
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0035354
Key People
Sumati Ganpat Patil Director Ganpat Mahadev Patil Director

Recognitions & Rankings of Suma Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-MH-33-0035354

Contact details

Suma Pharmaceuticals Private Limited's registered office is in Ambernath, Maharashtra. Its website is sumapharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    sumapharma.in
  • Registered Address
    Plot No.126 Chikhloli MIDC New Bhendipada, Ambernath, Maharashtra, India – 421501
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Suma Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Suma Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Suma Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Suma Pharmaceuticals Private Limited, buy the company report.

Financials of Suma Pharmaceuticals Private Limited

FY 2024 filings available

Suma Pharmaceuticals Private Limited reported revenue of ₹15.75 Cr (up 9% YoY) for FY 2024.

Revenue · FY 2024
₹15.75 Cr ▲ 9%
Net loss · FY 2024
₹46.31 Lakh margin -2.9%
EBITDA · FY 2024
₹2.66 Cr margin 16.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 5%
5 years · compounded
▲ 37%
EBITDA CAGR growth
1 year
▲ 90%
3 years · compounded
▲ 46%
5 years · compounded
▲ 38%

Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 9% growth in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹46.31 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin16.9%
Net Profit Margin-2.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Suma Pharmaceuticals Private Limited, buy the company report.

Board of directors of Suma Pharmaceuticals Private Limited

Suma Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sumati Ganpat Patil
Also directs: Aromatic and Industrial Chemicals Private Limited, Suma Chemicals Pvt. Ltd.
Director28 Dec 199728 Years 10 MonthsCurrent
Ganpat Mahadev Patil
Also directs: Aromatic and Industrial Chemicals Private Limited, Suma Chemicals Pvt. Ltd., Chikhloli Morivli Effluent Treatment
Director28 Dec 199728 Years 10 MonthsCurrent
View all directors

Peer comparison

Suma Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Oshino Drugs Private Limited₹15.75 Cr (FY 2025)-15.0%New Delhi, Delhi, India
Suma Pharmaceuticals Private Limitedthis company₹15.75 Cr (FY 2024)-₹46.31 Lakh-2.9%9.0%15Ambernath, Maharashtra, India
Syntho Pharmaceuticals Private Limited₹15.7 Cr (FY 2025)-3.0%Uttar Pradesh, India
Hfa Formulations Private Limited₹15.65 Cr (FY 2024)42.0%Chennai, Tamil Nadu, India
Eamon Drugs Private Limited₹15.64 Cr (FY 2025)24.0%Indore, Madhya Pradesh, India

To see the full peer comparison of Suma Pharmaceuticals Private Limited, buy the company report.

Auditor

Suma Pharmaceuticals Private Limited is audited by PRAVEEN KUMARMANIYAR for the financial year 2023.

Auditor firmFinancial yearFirm registration number
PRAVEEN KUMARMANIYARFY 2023147979

Shareholding

The shareholding of Suma Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Suma Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹58.58 Cr
Satisfied charges
₹26.16 Cr
Breakdown by lending institutions
Bank of India₹58.58 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 May 2023100731805Bank of India₹29.29 CrOpen
15 Mar 2023100698652Bank of India₹29.29 CrOpen
29 Jun 2022100587842Others₹2.3 CrSatisfied
19 Apr 2022100563706Others₹1.04 CrSatisfied
31 Dec 2021100539700Others₹1 CrSatisfied

To see the full charge records of Suma Pharmaceuticals Private Limited, buy the company report.

Total charge records: 14 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Suma Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Suma Pharmaceuticals Private Limited has a workforce of 15 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.

Employee count
15
Active EPFO establishments
1
Employee growth
7.14%

GST

Suma Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCS1935H1ZAMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Suma Pharmaceuticals Private Limited, buy the company report.

Recent activity

Suma Pharmaceuticals Private Limited has 2 board changes on record since 1997: 2 appointments. The latest: Ganpat Mahadev Patil was appointed as Director on 28 Dec 1997.

AGM
Suma Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Suma Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Bank Of India amounted to Rs. 29.29 Cr with Charge ID 100731805 was registered on 24 May 2023.
Charges
A charge registered on 31 Dec 2021 via Charge ID 100539700 with Others was fully satisfied on 05 May 2023.
Charges
A charge registered on 30 Sep 2018 via Charge ID 100231323 with Others was fully satisfied on 05 May 2023.
Charges
A charge registered on 29 Jun 2022 via Charge ID 100587842 with Others was fully satisfied on 26 Apr 2023.
Charges
A charge registered on 19 Apr 2022 via Charge ID 100563706 with Others was fully satisfied on 26 Apr 2023.
Charges
A charge registered on 30 Sep 2021 via Charge ID 100511466 with Others was fully satisfied on 26 Apr 2023.
Charges
A charge registered on 04 Jul 2020 via Charge ID 100352999 with Others was fully satisfied on 26 Apr 2023.
Charges
A charge with Bank Of India amounted to Rs. 29.29 Cr with Charge ID 100698652 was registered on 15 Mar 2023.
Charges
A charge with Others of Rs. 2.25 Cr registered on 04 Jul 2020 with Charge ID 100352999 was modified on 06 Jul 2022.
Charges
A charge with Others amounted to Rs. 2.30 Cr with Charge ID 100587842 was registered on 29 Jun 2022.

25 earlier events are in the company report.

Frequently asked questions

Suma Pharmaceuticals is an active private limited company based in Ambernath, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 August 1991 (35+ years old) and is registered under CIN U27100MH1991PTC062830.

Suma Pharmaceuticals has 2 current directors:

The latest financial statements of Suma Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Suma Pharmaceuticals is 27AAGCS1935H1ZA, registered in Maharashtra.

The CIN (Corporate Identification Number) of Suma Pharmaceuticals is U27100MH1991PTC062830. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Suma Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

Suma Pharmaceuticals was incorporated on 06 August 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Suma Pharmaceuticals by revenue are Oshino Drugs Private Limited, Syntho Pharmaceuticals Private Limited, Hfa Formulations Private Limited, Eamon Drugs Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ganpat Mahadev Patil was appointed as Director on 28 Dec 1997. Sumati Ganpat Patil was appointed as Director on 28 Dec 1997.

Yes, Suma Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0035354).

Suma Pharmaceuticals can be reached through the website sumapharma.in. Its registered office is in Ambernath, Maharashtra, India.